4//SEC Filing
Sarraf Pasha 4
Accession 0000950170-25-037889
CIK 0001645460other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:00 PM ET
Size
5.6 KB
Accession
0000950170-25-037889
Insider Transaction Report
Form 4
Sarraf Pasha
Director
Transactions
- Award
Stock Option (right to buy)
2025-03-10+48,800→ 48,800 totalExercise: $1.03Exp: 2035-03-09→ Common Stock (48,800 underlying)
Footnotes (2)
- [F1]Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
- [F2]This option was granted on March 10, 2025. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0002059447
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 4:00 PM ET
- Size
- 5.6 KB